Results 101 to 110 of about 967,120 (307)

Are we ready? Death and dying in the eyes of contemporary nurses

open access: yesJournal of Education, Health and Sport
This study explores the readiness of contemporary nurses to accompany patients through the process of dying. Although death is an inseparable part of life, it remains a taboo subject both in society and within the medical community.
Marta Polanowska, Sylwia Krzeminska
doaj   +1 more source

Physician Assisted Dying as an Extension of Healing [PDF]

open access: yes, 2018
The role of a physician is to provide care for those who seek their assistance. Lisa Yount attributes the most ancient statement about this activity to the Hippocratic Oath.
Marinacci, Zoe I.
core   +1 more source

Organ‐specific redox imbalances in spinal muscular atrophy mice are partially rescued by SMN antisense oligonucleotides

open access: yesFEBS Letters, EarlyView.
We identified a systemic, progressive loss of protein S‐glutathionylation—detected by nonreducing western blotting—alongside dysregulation of glutathione‐cycle enzymes in both neuronal and peripheral tissues of Taiwanese SMA mice. These alterations were partially rescued by SMN antisense oligonucleotide therapy, revealing persistent redox imbalance as ...
Sofia Vrettou, Brunhilde Wirth
wiley   +1 more source

β‐TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1

open access: yesMolecular Oncology, EarlyView.
Low levels of β‐TrCP (Panel A) allow the accumulation of BRCA1 and CtIP, which facilitate the repair of cisplatin‐induced DNA damage via homologous recombination (HR) and promote tumor cell survival. In contrast, high β‐TrCP expression (Panel B) leads to BRCA1 and CtIP degradation, impairing HR repair, resulting in persistent DNA damage and apoptosis ...
Rocío Jiménez‐Guerrero   +8 more
wiley   +1 more source

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham   +21 more
wiley   +1 more source

“We Want to Talk about Death, Dying and Grief and to Learn about End-of-Life Care”—Lessons Learned from a Multi-Center Mixed-Methods Study on Last Aid Courses for Kids and Teens

open access: yesChildren
Background: Last Aid Courses (LAC) for adults have been established in 21 countries in Europe, Australia and America to improve the public discussion about death and dying and to empower people to participate in end-of-life care provision.
Georg Bollig   +4 more
doaj   +1 more source

Confronting Death: Co-infection with HIV/AIDS and Hepatitis C [PDF]

open access: yes, 2008
This paper discusses a qualitative study completed by the researcher revealing the need for assistance for people living with a co-infection of HIV/AIDS and hepatitis C. It is the role of a social worker to assist this at-risk population.
Parker, Ian
core   +1 more source

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

open access: yesMolecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy   +9 more
wiley   +1 more source

Dying to research: An autoethnographic exploration of researching Māori and whānau experiences of end-of-life care [PDF]

open access: yes, 2010
The authors critically reflect on the autoethnographic process involved in navigating a smooth pathway towards investigating dying, death and bereavement for Māori whānau (families) in a way that supports and gives voice to their experience.
Moeke-Maxwell, Tess   +2 more
core  

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

open access: yesMolecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy